TrialBMC medicine2025

Lipid metabolism associated with efficacy of metronomic capecitabine and camrelizumab in gastrointestinal cancer: an exploratory clinical trial.

Chenfei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.